Methodological Issues in Economic Assessments of New Therapies

This publication has 10 references indexed in Scilit:

• In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care
  Medical Care, 1994
• Clinical importance, statistical significance and the assessment of economic and quality‐of‐life outcomes
  Health Economics, 1993
• Economic evaluation of pharmaceuticals: a European perspective.
  1993
• Assessment of Costs and Benefits of Drug Therapy for Treatment-Resistant Schizophrenia in the United Kingdom
  The British Journal of Psychiatry, 1993
• Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status?
  Health Economics, 1992
• Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
  New England Journal of Medicine, 1991
• Clozapine's cost-benefits.
  1991
• Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues
  International Journal of Technology Assessment in Health Care, 1991
• Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.
  BMJ, 1990
• Cost-Effectiveness of Clozapine for Treatment-Resistant Schizophrenic Patients
  Psychiatric Services, 1990